Literature DB >> 229719

Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen.

S Fahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229719

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  14 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Myoclonus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

3.  The Lance-Adams syndrome following cardiopulmonary resuscitation: A report of two cases.

Authors:  H Yamaoka; N Tomemori; K Hayama
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

4.  Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide.

Authors:  M G Goetting
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

5.  Computed tomography in the management of complications due to ventricular shunting.

Authors:  R H Gooskens; M C Kaiser; J A Veiga-Pires
Journal:  Neuroradiology       Date:  1981-02       Impact factor: 2.804

6.  On the significance of giant somatosensory evoked potentials in cortical myoclonus.

Authors:  J C Rothwell; J A Obeso; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

7.  Post-hypoxic action (intention) myoclonus: a clinico-electroencephalographic study.

Authors:  O W Witte; E Niedermeyer; G Arendt; H J Freund
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

Review 8.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

9.  Myoclonus.

Authors:  Victoria C Chang; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

10.  Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.

Authors:  K-K Tai; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.